Gadot Harel 4
4 · Microbot Medical Inc. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Gadot Harel
DirectorChairman, President and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-22+80,000→ 80,000 totalExercise: $1.27From: 2024-02-22Exp: 2034-02-22→ Common Stock, par value $0.01 per share (80,000 underlying) - Award
Stock Option (Right to Buy)
2024-02-26+79,567→ 79,567 totalExercise: $1.25From: 2024-02-26Exp: 2034-02-26→ Common Stock, par value $0.01 per share (79,567 underlying) - Award
Stock Option (Right to Buy)
2024-02-22+80,000→ 80,000 totalExercise: $1.27Exp: 2034-02-22→ Common Stock, par value $0.01 per share (80,000 underlying)
Footnotes (1)
- [F1]The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.